Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.53 USD | -1.33% | +3.81% | -19.65% |
May. 09 | Intellia Therapeutics' Q1 Net Loss Narrows, Collaboration Revenue Rises | MT |
May. 09 | Transcript : Intellia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 51.63M | Sales 2025 * | 53.44M | Capitalization | 2.4B |
---|---|---|---|---|---|
Net income 2024 * | -502M | Net income 2025 * | -523M | EV / Sales 2024 * | 32.5 x |
Net cash position 2024 * | 721M | Net cash position 2025 * | 1.18B | EV / Sales 2025 * | 22.7 x |
P/E ratio 2024 * |
-4.52
x | P/E ratio 2025 * |
-4.72
x | Employees | 526 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.8% |
Latest transcript on Intellia Therapeutics, Inc.
1 day | +8.09% | ||
1 week | +6.83% | ||
Current month | +16.17% | ||
1 month | -4.68% | ||
3 months | -11.94% | ||
6 months | -0.40% | ||
Current year | -18.47% |
Managers | Title | Age | Since |
---|---|---|---|
John Leonard
CEO | Chief Executive Officer | 66 | 14-06-30 |
Glenn Goddard
DFI | Director of Finance/CFO | 53 | 18-10-28 |
Eliana Clark
CTO | Chief Tech/Sci/R&D Officer | 67 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Cohen
BRD | Director/Board Member | 67 | 19-01-23 |
John Leonard
CEO | Chief Executive Officer | 66 | 14-06-30 |
Frank Verwiel
CHM | Chairman | 62 | 17-07-23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
11.15% | 2 M€ | -25.75% | ||
4.87% | 0 M€ | 0.00% | - | |
4.17% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 24.5 | -1.45% | 917 947 |
24-05-09 | 24.86 | +8.09% | 1,669,933 |
24-05-08 | 23 | -3.69% | 1,375,019 |
24-05-07 | 23.88 | +0.67% | 1,096,319 |
24-05-06 | 23.72 | +0.51% | 1,495,293 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.47% | 2.4B | |
+23.37% | 47.02B | |
+49.90% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- NTLA Stock